non-addictive analgesic

PreveCeutical's **non-addictive analgesic** is a peptide-based therapeutic candidate currently in preclinical development for the management of moderate-to-severe pain. Developed by **PreveCeutical Medical Inc.** in collaboration with the **University of Queensland**, the program focuses on identifying and optimizing stable, disulfide-rich peptides (such as cyclotides) that provide potent pain relief. Unlike traditional opioid-based therapies, this candidate is designed to act through non-opioid pathways, thereby eliminating the risks of addiction, physical dependence, and respiratory depression. The program aims to provide a safer alternative for patients requiring long-term or high-potency pain management.

Other names

PreveCeutical non-addictive analgesicNon-Addictive Analgesic Program